Nasus Pharma Ltd. engages in the development of intranasal drugs for emergency medical conditions. It offers Powder-Based Intranasal (PBI) specialized product portfolio, to address acute medical conditions and public health threats. The company was founded by Udi Gilboa and Dalia Megiddo in May 2019 and is headquartered in Tel Aviv, Israel. The company trades on AMEX exchange. The company headquarter is located in Israel.

TickerNSRX
Long NameNasus Pharma Ltd
Short NameNasus Pharma